Back to search

University of Patras

Ανοσολογικές αποκρίσεις πεπτιδικών αναλόγων της μυελίνης συζευγμένα με μαννάνη ή αναμεμειγμένα με ανοσοενισχυτικό CFA σε πειραματικά μοντέλα της σκλήρυνσης κατά πλάκας

Abstract

dc:description

Multiple sclerosis (MS) is a commonly occurring chronic, inflammatory and disabling disorder of the central nervous system (CNS). It is widely considered that CD4+ T helper type 1 (Th1) cells play a pivotal role in mediating an autoimmune attack against components of myelin sheath. Additional cells, such as CD8+ T cells, macrophages and complement are also involved in axonal damage and neurodegeneration. Several autoantigens, such as myelin basic protein (MBP), proteolipid protein (PLP) and myelin oligodendrocyte glycoprotein (MOG) have been proposed as candidate antigens in the induction of MS based on auto-T cells and auto-antibodies which are present in patients with MS. The design of peptide mutants of disease-associated myelin epitopes to alter immune responses from Th1 to Th2 offers a promising avenue for the treatment of MS. Hence, a number of peptides were designed and synthesised by mutating principal TCR contact residues based on MBP87-99, MBP83-99 and PLP139-151 peptide epitopes in their linear or cyclic forms. Peptides were either emulsified in equal volumes of complete Freund’s adjuvant (CFA) and phosphate buffer saline (PBS) or conjugated to reduced mannan via a KLH linker, in order to examine their cytokine and antibody profile. Mannan was previously found to generate either a Th1 response (IL-2, IFN-γ,? IL-12, TNF-α and IgG2a antibodies) or Th2 response (not IFN-γ or IL-12, but significant amounts of IL-4, IL-10 and TGF-β and IgG1 antibodies) depending on the mode of conjugation, oxidised or reduced mannan, respectively. IFN-γ, IL-4 and IL-10 or antagonism experiments were conducted using a capture ELISpot method, proliferation assays were performed to evaluate the regulation of the peptides in vitro and ELISA was performed to assess antibody responses in vivo. We noted that the use of CFA with either MBP87-99 or MBP83-99 mutant peptide analogues, in general, for immunisation, induced higher levels of IFN-γ and lower levels of IL-4, when mutant analogues were used. However, very high levels of IL-4 and IL-10 and no IFN-γ were secreted by T cells, when mice were immunised with reduced mannan peptide conjugates. Antibody responses to native peptide, mutant peptides, linear and cyclic peptides and to whole MBP protein, in addition to, T cell proliferation and EAE experiments were also been assessed. Overall, the linear [Y91]MBP83-99 peptide conjugated to reduced mannan showed the best cytokine and antibody profile and could antagonise T cell responses in vitro, thus, gives promise for the immunotherapy of MS and needs to be pursued for further testing in human studies. For the first time, structural alignment of existing crystal structures revealed the peptide binding motif of H2 I-As (MHC class II). Molecular modelling was used to identify novel H-bonds and van der Waals interactions between peptides and MΗC (I-As). Finally, mannosylation of PLP139-151 peptide could protect mice from EAE in a prophylactic vaccination setting.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2008

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Katsara, Maria
  • Κατσάρα, Μαρία

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/17929

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Katsara, Maria; Κατσάρα, Μαρία. Ανοσολογικές αποκρίσεις πεπτιδικών αναλόγων της μυελίνης συζευγμένα με μαννάνη ή αναμεμειγμένα με ανοσοενισχυτικό CFA σε πειραματικά μοντέλα της σκλήρυνσης κατά πλάκας. University of Patras, 2008. http://hdl.handle.net/10442/hedi/17929